Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Urnauer

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Oncotarget|July 27, 2016
Hypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene deliveryAndrea M Müller, Kathrin A Schmohl, Kerstin Knoop, et al.
Molecular Cancer Research : MCR|September 19, 2018
A Novel Approach for Image-Guided Christina Schug, Aayush Gupta, Sarah Urnauer, et al.
EJNMMI Research|May 3, 2022
The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapyCarolin Kitzberger, Rebekka Spellerberg, Volker Morath, et al.
Theranostics|April 16, 2020
Effective control of tumor growth through spatial and temporal control of theranostic sodium iodide symporter (<i>NIS</i>) gene expression using a heat-inducible gene promoter in engineered mesenchymal stem cellsMariella Tutter, Christina Schug, Kathrin A Schmohl, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 17, 2020
Regional Hyperthermia Enhances Mesenchymal Stem Cell Recruitment to Tumor Stroma: Implications for Mesenchymal Stem Cell-Based Tumor TherapyMariella Tutter, Christina Schug, Kathrin A Schmohl, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Oncotarget|July 27, 2016
Hypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene deliveryAndrea M Müller, Kathrin A Schmohl, Kerstin Knoop, et al.
Molecular Cancer Research : MCR|September 19, 2018
A Novel Approach for Image-Guided Christina Schug, Aayush Gupta, Sarah Urnauer, et al.
EJNMMI Research|May 3, 2022
The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapyCarolin Kitzberger, Rebekka Spellerberg, Volker Morath, et al.
Theranostics|April 16, 2020
Effective control of tumor growth through spatial and temporal control of theranostic sodium iodide symporter (<i>NIS</i>) gene expression using a heat-inducible gene promoter in engineered mesenchymal stem cellsMariella Tutter, Christina Schug, Kathrin A Schmohl, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 17, 2020
Regional Hyperthermia Enhances Mesenchymal Stem Cell Recruitment to Tumor Stroma: Implications for Mesenchymal Stem Cell-Based Tumor TherapyMariella Tutter, Christina Schug, Kathrin A Schmohl, et al.
Pageof 2